These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33051740)

  • 1. Verification of the Optimal Interval Before Esophagectomy After Preoperative Neoadjuvant Chemoradiotherapy for Locally Advanced Thoracic Esophageal Cancer.
    Wakita A; Motoyama S; Sato Y; Nagaki Y; Fujita H; Terata K; Imai K; Minamiya Y
    Ann Surg Oncol; 2021 Apr; 28(4):2101-2110. PubMed ID: 33051740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of and perspectives regarding neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
    Saeki H; Nakashima Y; Zaitsu Y; Tsuda Y; Kasagi Y; Ando K; Imamura Y; Ohgaki K; Ito S; Kimura Y; Egashira A; Oki E; Morita M; Maehara Y
    Surg Today; 2016 Mar; 46(3):261-7. PubMed ID: 25740123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns and timing of recurrence in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy plus esophagectomy.
    Nagaki Y; Motoyama S; Sato Y; Wakita A; Fujita H; Sasaki Y; Imai K; Minamiya Y
    BMC Cancer; 2021 Nov; 21(1):1192. PubMed ID: 34753448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Neoadjuvant Chemoradiotherapy Following Esophagectomy with Japanese-style Extended 3-Field Lymphadenectomy for Thoracic Esophageal Cancer.
    Motoyama S; Sato Y; Sasaki T; Wakita A; Kawakita Y; Liu J; Nagaki Y; Saito H; Imai K; Konno H; Mizusawa KT; Minamiya Y
    Anticancer Res; 2017 Oct; 37(10):5837-5843. PubMed ID: 28982909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreases in the Psoas Muscle Index Correlate More Strongly with Survival than Other Prognostic Markers in Esophageal Cancer After Neoadjuvant Chemoradiotherapy Plus Esophagectomy.
    Kawakita Y; Motoyama S; Sato Y; Wakita A; Nagaki Y; Imai K; Minamiya Y
    World J Surg; 2020 May; 44(5):1559-1568. PubMed ID: 31907570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUV
    Nagaki Y; Motoyama S; Sato Y; Wakita A; Fujita H; Sasaki Y; Imai K; Minamiya Y
    World J Surg Oncol; 2021 Apr; 19(1):105. PubMed ID: 33836789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged interval between neoadjuvant chemoradiotherapy and esophagectomy does not benefit the outcome in esophageal cancer: a systematic review and meta-analysis.
    Tie H; He F; Shen J; Zhang B; Ye M; Chen B; Wu Q
    Dis Esophagus; 2018 Jan; 31(1):1-9. PubMed ID: 29087451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing the interval between neoadjuvant chemoradiotherapy and surgery in esophageal cancer: a meta-analysis of published studies.
    Lin G; Han SY; Xu YP; Mao WM
    Dis Esophagus; 2016 Nov; 29(8):1107-1114. PubMed ID: 26542065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative chemoradiation therapy for esophageal cancer is a risk factor for the elevation of high mobility group box-1, leading to an increase in postoperative severe pulmonary complications.
    Takahata R; Ono S; Tsujimoto H; Hiraki S; Aosasa S; Yamamoto J; Hase K
    Dis Esophagus; 2016 Jan; 29(1):70-8. PubMed ID: 25139532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does timing of esophagectomy following neoadjuvant chemoradiation affect outcomes? A meta-analysis.
    Qin Q; Xu H; Liu J; Zhang C; Xu L; Di X; Zhang X; Sun X
    Int J Surg; 2018 Nov; 59():11-18. PubMed ID: 30261331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between time interval from neoadjuvant chemoradiotherapy to surgery and complete histological tumor response in esophageal and gastroesophageal junction cancer: a national cohort study.
    Klevebro F; Nilsson K; Lindblad M; Ekman S; Johansson J; Lundell L; Ndegwa N; Hedberg J; Nilsson M
    Dis Esophagus; 2020 May; 33(5):. PubMed ID: 31676895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is esophagectomy necessary for esophageal cancer patients with complete response after neoadjuvant chemoradiotherapy].
    Fu J; Tan Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):983-986. PubMed ID: 30269316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer.
    Haisley KR; Hart KD; Nabavizadeh N; Bensch KG; Vaccaro GM; Thomas CR; Schipper PH; Hunter JG; Dolan JP
    Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life following neoadjuvant chemoradiotherapy versus perioperative chemotherapy and esophagectomy for esophageal cancer: a European multicenter study.
    Schuring N; Markar SR; Hagens ERC; Jezerskyte E; Sprangers MAG; Lagergren P; Johar A; Gisbertz SS; van Berge Henegouwen MI;
    Dis Esophagus; 2023 Mar; 36(4):. PubMed ID: 36241253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant Chemotherapy versus Chemoradiation Prior to Esophagectomy: Impact on Rate of Complete Pathologic Response and Survival in Esophageal Cancer Patients.
    Samson P; Robinson C; Bradley J; Lockhart AC; Puri V; Broderick S; Kreisel D; Krupnick AS; Patterson GA; Meyers B; Crabtree T
    J Thorac Oncol; 2016 Dec; 11(12):2227-2237. PubMed ID: 27544058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical features and risk factors of anastomotic leakage after radical esophagectomy].
    Chen C; Yu Z; Jin Q; Zhang X
    Zhonghua Wai Ke Za Zhi; 2015 Jul; 53(7):518-21. PubMed ID: 26359075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of minimally invasive esophagectomy in esophageal cancer after neoadjuvant chemoradiotherapy.
    Warner S; Chang YH; Paripati H; Ross H; Ashman J; Harold K; Day R; Stucky CC; Rule W; Jaroszewski D
    Ann Thorac Surg; 2014 Feb; 97(2):439-45. PubMed ID: 24266955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimally Invasive Esophagectomy with Thoracic Duct Resection Post Neoadjuvant Chemoradiotherapy for Carcinoma Esophagus-Impact on Lymph Node Yield and Hemodynamic Parameters.
    Anand S; Kalayarasan R; Chandrasekar S; Gnanasekaran S; Pottakkat B
    J Gastrointest Cancer; 2019 Jun; 50(2):230-235. PubMed ID: 29344808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Timing of esophagectomy in multimodal therapy of esophageal cancer: Impact of time interval between neoadjuvant therapy and surgery on outcome and response].
    Müller AK; Lenschow C; Palmes D; Senninger N; Hummel R; Lindner K
    Chirurg; 2015 Sep; 86(9):874-80. PubMed ID: 25662991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of neoadjuvant chemoradiotherapy on postoperative morbidity and mortality associated with esophageal cancer.
    Hamai Y; Hihara J; Taomoto J; Yamakita I; Ibuki Y; Okada M
    Dis Esophagus; 2015; 28(4):358-64. PubMed ID: 24612033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.